Codiak BioSciences collaborates with Ragon Institute to evaluate exoVACC vaccine platform in SARS-CoV-2 and HIV

Codiak BioSciences has collaborated with Ragon Institute to evaluate exoVACC vaccine platform in SARS-CoV-2 and HIV. (Credit: Gerd Altmann from Pixabay)